US Stock MarketDetailed Quotes

Xenetic Biosciences (XBIO)

Watchlist
  • 2.980
  • +0.050+1.71%
Trading May 19 15:19 ET
6.83MMarket Cap-2.50P/E (TTM)

Xenetic Biosciences (XBIO) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q1)Mar 31, 2026
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
42.29%7.35M
27.87%7.88M
27.87%7.88M
-39.74%4.12M
-34.51%4.78M
-34.00%5.16M
-31.36%6.17M
-31.36%6.17M
-30.04%6.84M
-31.95%7.3M
-Cash and cash equivalents
42.29%7.35M
27.87%7.88M
27.87%7.88M
-39.74%4.12M
-34.51%4.78M
-34.00%5.16M
-31.36%6.17M
-31.36%6.17M
-30.04%6.84M
-31.95%7.3M
Receivables
----
----
----
----
----
----
----
----
----
--716.38K
-Accounts receivable
----
----
----
----
----
----
----
----
----
--716.38K
Other current assets
-20.98%247.82K
-60.59%166.29K
-60.59%166.29K
403.15%946.36K
--573.85K
-43.19%313.62K
-30.12%421.95K
-30.12%421.95K
-87.30%188.09K
----
Total current assets
38.66%7.6M
22.20%8.05M
22.20%8.05M
-27.89%5.07M
-33.20%5.35M
-34.61%5.48M
-31.29%6.59M
-31.29%6.59M
-37.57%7.03M
-33.46%8.01M
Non current assets
Other non current assets
0.00%313.92K
0.00%313.92K
0.00%313.92K
----
----
-69.17%313.92K
-69.17%313.92K
-69.17%313.92K
44.56%1.02M
44.56%1.02M
Total non current assets
0.00%313.92K
0.00%313.92K
0.00%313.92K
--0
--0
-69.17%313.92K
-69.17%313.92K
-69.17%313.92K
44.56%1.02M
44.56%1.02M
Total assets
36.57%7.91M
21.19%8.36M
21.19%8.36M
-37.01%5.07M
-40.73%5.35M
-38.35%5.79M
-34.92%6.9M
-34.92%6.9M
-32.73%8.05M
-29.15%9.03M
Liabilities
Current liabilities
Payables
132.55%558.81K
-8.99%258.11K
-8.99%258.11K
137.63%578.25K
22.30%346.83K
14.16%240.29K
17.76%283.62K
17.76%283.62K
-45.75%243.34K
28.16%283.59K
-accounts payable
132.55%558.81K
-8.99%258.11K
-8.99%258.11K
137.63%578.25K
22.30%346.83K
14.16%240.29K
17.76%283.62K
17.76%283.62K
-45.75%243.34K
28.16%283.59K
Current accrued expenses
-6.60%399.43K
19.01%686.04K
19.01%686.04K
-30.36%533.53K
-57.32%556.6K
-15.49%427.63K
10.75%576.45K
10.75%576.45K
23.57%766.06K
100.61%1.3M
Other current liabilities
----
-30.20%23.88K
-30.20%23.88K
----
----
----
-29.12%34.2K
-29.12%34.2K
----
----
Current liabilities
43.46%958.24K
8.25%968.03K
8.25%968.03K
10.14%1.11M
-43.09%903.43K
-6.78%667.93K
10.46%894.26K
10.46%894.26K
-5.53%1.01M
82.21%1.59M
Non current liabilities
Total non current liabilities
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Total liabilities
43.46%958.24K
8.25%968.03K
8.25%968.03K
10.14%1.11M
-43.09%903.43K
-6.78%667.93K
10.46%894.26K
10.46%894.26K
-5.53%1.01M
82.21%1.59M
Shareholders'equity
Share capital
11.91%3.75K
11.91%3.75K
11.91%3.75K
0.00%3.35K
0.03%3.35K
0.03%3.35K
0.03%3.35K
0.03%3.35K
-22.30%3.35K
-22.32%3.35K
-common stock
48.48%2.29K
48.48%2.29K
48.48%2.29K
0.00%1.55K
0.06%1.55K
0.06%1.55K
0.06%1.55K
0.06%1.55K
0.59%1.55K
0.52%1.54K
-Preferred stock
-19.40%1.45K
-19.40%1.45K
-19.40%1.45K
0.00%1.8K
0.00%1.8K
0.00%1.8K
0.00%1.8K
0.00%1.8K
-34.97%1.8K
-34.97%1.8K
Retained earnings
-1.13%-200.33M
-1.36%-199.88M
-1.36%-199.88M
-1.61%-199.3M
-1.58%-198.79M
-1.89%-198.1M
-2.05%-197.19M
-2.05%-197.19M
-2.12%-196.14M
-2.46%-195.7M
Paid-in capital
1.95%212.31M
1.95%212.29M
1.95%212.29M
0.04%208.28M
0.04%208.26M
0.05%208.24M
0.08%208.23M
0.08%208.23M
0.11%208.2M
0.13%208.17M
Less: Treasury stock
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
0.00%5.28M
Gains losses not affecting retained earnings
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
0.00%253.73K
Total stockholders'equity
35.67%6.95M
23.12%7.4M
23.12%7.4M
-43.78%3.96M
-40.23%4.45M
-40.96%5.12M
-38.67%6.01M
-38.67%6.01M
-35.40%7.04M
-37.31%7.45M
Total equity
35.67%6.95M
23.12%7.4M
23.12%7.4M
-43.78%3.96M
-40.23%4.45M
-40.96%5.12M
-38.67%6.01M
-38.67%6.01M
-35.40%7.04M
-37.31%7.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion
--
--
--
(Q1)Mar 31, 2026(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 42.29%7.35M27.87%7.88M27.87%7.88M-39.74%4.12M-34.51%4.78M-34.00%5.16M-31.36%6.17M-31.36%6.17M-30.04%6.84M-31.95%7.3M
-Cash and cash equivalents 42.29%7.35M27.87%7.88M27.87%7.88M-39.74%4.12M-34.51%4.78M-34.00%5.16M-31.36%6.17M-31.36%6.17M-30.04%6.84M-31.95%7.3M
Receivables --------------------------------------716.38K
-Accounts receivable --------------------------------------716.38K
Other current assets -20.98%247.82K-60.59%166.29K-60.59%166.29K403.15%946.36K--573.85K-43.19%313.62K-30.12%421.95K-30.12%421.95K-87.30%188.09K----
Total current assets 38.66%7.6M22.20%8.05M22.20%8.05M-27.89%5.07M-33.20%5.35M-34.61%5.48M-31.29%6.59M-31.29%6.59M-37.57%7.03M-33.46%8.01M
Non current assets
Other non current assets 0.00%313.92K0.00%313.92K0.00%313.92K---------69.17%313.92K-69.17%313.92K-69.17%313.92K44.56%1.02M44.56%1.02M
Total non current assets 0.00%313.92K0.00%313.92K0.00%313.92K--0--0-69.17%313.92K-69.17%313.92K-69.17%313.92K44.56%1.02M44.56%1.02M
Total assets 36.57%7.91M21.19%8.36M21.19%8.36M-37.01%5.07M-40.73%5.35M-38.35%5.79M-34.92%6.9M-34.92%6.9M-32.73%8.05M-29.15%9.03M
Liabilities
Current liabilities
Payables 132.55%558.81K-8.99%258.11K-8.99%258.11K137.63%578.25K22.30%346.83K14.16%240.29K17.76%283.62K17.76%283.62K-45.75%243.34K28.16%283.59K
-accounts payable 132.55%558.81K-8.99%258.11K-8.99%258.11K137.63%578.25K22.30%346.83K14.16%240.29K17.76%283.62K17.76%283.62K-45.75%243.34K28.16%283.59K
Current accrued expenses -6.60%399.43K19.01%686.04K19.01%686.04K-30.36%533.53K-57.32%556.6K-15.49%427.63K10.75%576.45K10.75%576.45K23.57%766.06K100.61%1.3M
Other current liabilities -----30.20%23.88K-30.20%23.88K-------------29.12%34.2K-29.12%34.2K--------
Current liabilities 43.46%958.24K8.25%968.03K8.25%968.03K10.14%1.11M-43.09%903.43K-6.78%667.93K10.46%894.26K10.46%894.26K-5.53%1.01M82.21%1.59M
Non current liabilities
Total non current liabilities --0--0--0--0--0--0--0--0--0--0
Total liabilities 43.46%958.24K8.25%968.03K8.25%968.03K10.14%1.11M-43.09%903.43K-6.78%667.93K10.46%894.26K10.46%894.26K-5.53%1.01M82.21%1.59M
Shareholders'equity
Share capital 11.91%3.75K11.91%3.75K11.91%3.75K0.00%3.35K0.03%3.35K0.03%3.35K0.03%3.35K0.03%3.35K-22.30%3.35K-22.32%3.35K
-common stock 48.48%2.29K48.48%2.29K48.48%2.29K0.00%1.55K0.06%1.55K0.06%1.55K0.06%1.55K0.06%1.55K0.59%1.55K0.52%1.54K
-Preferred stock -19.40%1.45K-19.40%1.45K-19.40%1.45K0.00%1.8K0.00%1.8K0.00%1.8K0.00%1.8K0.00%1.8K-34.97%1.8K-34.97%1.8K
Retained earnings -1.13%-200.33M-1.36%-199.88M-1.36%-199.88M-1.61%-199.3M-1.58%-198.79M-1.89%-198.1M-2.05%-197.19M-2.05%-197.19M-2.12%-196.14M-2.46%-195.7M
Paid-in capital 1.95%212.31M1.95%212.29M1.95%212.29M0.04%208.28M0.04%208.26M0.05%208.24M0.08%208.23M0.08%208.23M0.11%208.2M0.13%208.17M
Less: Treasury stock 0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M0.00%5.28M
Gains losses not affecting retained earnings 0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K0.00%253.73K
Total stockholders'equity 35.67%6.95M23.12%7.4M23.12%7.4M-43.78%3.96M-40.23%4.45M-40.96%5.12M-38.67%6.01M-38.67%6.01M-35.40%7.04M-37.31%7.45M
Total equity 35.67%6.95M23.12%7.4M23.12%7.4M-43.78%3.96M-40.23%4.45M-40.96%5.12M-38.67%6.01M-38.67%6.01M-35.40%7.04M-37.31%7.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions --Unqualified Opinion with Explanatory Notes--------Unqualified Opinion------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
On May 19 Eastern Time, Trump warned that Iran might only have a negotiating window until Sunday or early next week, adding that 'it may be Show More